Paper Details

  1. Home
  2. Paper Details

Pharmacokinetics of tranexamic acid during cardiopulmonary bypass.

Author: ButterworthJohn, CarrollJo A, ChengDavy C, DowdNoreen P, JamesRobert L, KarskiJacek M, LinYonggu

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study investigated the pharmacokinetics of tranexamic acid (TA) during heart surgery with cardiopulmonary bypass (CPB). The study aimed to develop more precise dosing strategies for TA in this setting.
Paper Details　
Original Abstract of the Article :
Tranexamic acid (TA) reduces blood loss and blood transfusion during heart surgery with cardiopulmonary bypass (CPB). TA dosing has been empiric because only limited pharmacokinetic studies have been reported, and CPB effects have not been characterized. We hypothesized that many of the published TA...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1097/00000542-200208000-00016

データ提供：米国国立医学図書館（NLM）

Tranexamic Acid: A Key Player in Heart Surgery

Heart surgery is a complex and delicate procedure, often requiring blood transfusions. This study investigates the pharmacokinetics of tranexamic acid (TA) during cardiopulmonary bypass (CPB), aiming to optimize its use to reduce blood loss and transfusion requirements.

Understanding the Sands of Pharmacokinetics

The study explores the complexities of TA pharmacokinetics during CPB, attempting to navigate the shifting sands of drug distribution and elimination. The researchers used pharmacokinetic modeling and simulation to analyze existing TA dosing techniques, seeking to find a more precise approach to managing TA concentrations.

A New Approach to Blood Loss Management

The study suggests that a more tailored approach to TA dosing could be beneficial in reducing blood loss during heart surgery with CPB. This research is like finding a hidden oasis in the desert of heart surgery, offering a potential strategy for optimizing TA use and improving patient outcomes.

Dr. Camel's Conclusion

This study highlights the importance of optimizing TA dosing during heart surgery with CPB. Understanding the pharmacokinetics of TA is crucial for minimizing blood loss and reducing the need for transfusions, ultimately leading to better patient outcomes.

Date :
  1. Date Completed 2002-09-10
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

12151929

DOI: Digital Object Identifier

10.1097/00000542-200208000-00016

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.